Question 1

What are the potential benefits of combining endostatin with the EGFR-TKI?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC clinical trial (NCT03008109). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC clinical trial (NCT03008109). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC clinical trial (NCT03008109). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC clinical trial (NCT03008109). Contact the study team or your healthcare provider for specific answers.

Question 5

What criteria will determine if I can continue in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC clinical trial (NCT03008109). Contact the study team or your healthcare provider for specific answers.

What this study is about